These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33398090)

  • 1. Correction to: Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner.
    Eysert F; Coulon A; Boscher E; Vreulx AC; Flaig A; Mendes T; Hughes S; Grenier-Boley B; Hanoulle X; Demiautte F; Bauer C; Marttinen M; Takalo M; Amouyel P; Desai S; Pike I; Hiltunen M; Chécler F; Farinelli M; Delay C; Malmanche N; Hébert SS; Dumont J; Kilinc D; Lambert JC; Chapuis J
    Mol Psychiatry; 2021 Oct; 26(10):5608. PubMed ID: 33398090
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner.
    Eysert F; Coulon A; Boscher E; Vreulx AC; Flaig A; Mendes T; Hughes S; Grenier-Boley B; Hanoulle X; Demiautte F; Bauer C; Marttinen M; Takalo M; Amouyel P; Desai S; Pike I; Hiltunen M; Chécler F; Farinelli M; Delay C; Malmanche N; Hébert SS; Dumont J; Kilinc D; Lambert JC; Chapuis J
    Mol Psychiatry; 2021 Oct; 26(10):5592-5607. PubMed ID: 33144711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Amyloid Precursor Protein Intracellular Domain Is an Effector Molecule of Metaplasticity.
    Trillaud-Doppia E; Boehm J
    Biol Psychiatry; 2018 Mar; 83(5):406-415. PubMed ID: 28168961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
    Chapuis J; Flaig A; Grenier-Boley B; Eysert F; Pottiez V; Deloison G; Vandeputte A; Ayral AM; Mendes T; Desai S; Goate AM; Kauwe JSK; Leroux F; Herledan A; Demiautte F; Bauer C; Checler F; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Albert M; Moghekar A; O'Brien R; Peskind ER; Malmanche N; Schellenberg GD; Dourlen P; Song OR; Cruchaga C; Amouyel P; Deprez B; Brodin P; Lambert JC;
    Acta Neuropathol; 2017 Jun; 133(6):955-966. PubMed ID: 27933404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity.
    Rusu P; Jansen A; Soba P; Kirsch J; Löwer A; Merdes G; Kuan YH; Jung A; Beyreuther K; Kjaerulff O; Kins S
    Eur J Neurosci; 2007 Feb; 25(4):1079-86. PubMed ID: 17331204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
    Chan SL; Furukawa K; Mattson MP
    Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate receptor delocalization in postsynaptic membrane and reduced hippocampal synaptic plasticity in the early stage of Alzheimer's disease.
    Li N; Li Y; Li LJ; Zhu K; Zheng Y; Wang XM
    Neural Regen Res; 2019 Jun; 14(6):1037-1045. PubMed ID: 30762016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer's Disease.
    Xu L; Zhou Y; Hu L; Jiang H; Dong Y; Shen H; Lou Z; Yang S; Ji Y; Ruan L; Zhang X
    Front Aging Neurosci; 2021; 13():772980. PubMed ID: 34916926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.
    Ma H; Lesné S; Kotilinek L; Steidl-Nichols JV; Sherman M; Younkin L; Younkin S; Forster C; Sergeant N; Delacourte A; Vassar R; Citron M; Kofuji P; Boland LM; Ashe KH
    Proc Natl Acad Sci U S A; 2007 May; 104(19):8167-72. PubMed ID: 17470798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.
    Ma T; Trinh MA; Wexler AJ; Bourbon C; Gatti E; Pierre P; Cavener DR; Klann E
    Nat Neurosci; 2013 Sep; 16(9):1299-305. PubMed ID: 23933749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphatase PTP1B impairs presynaptic NMDA receptor-mediated plasticity in a mouse model of Alzheimer's disease.
    Zhang L; Qin Z; Sharmin F; Lin W; Ricke KM; Zasloff MA; Stewart AFR; Chen HH
    Neurobiol Dis; 2021 Aug; 156():105402. PubMed ID: 34044147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer's Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP/PS1 Transgenic Mice.
    Li K; Jiang Y; Li G; Liu T; Yang Z
    ACS Chem Neurosci; 2020 Dec; 11(24):4316-4328. PubMed ID: 33216529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1-Mediated Macrophage Infiltration.
    Sossey-Alaoui K; Pluskota E; Bialkowska K; Szpak D; Parker Y; Morrison CD; Lindner DJ; Schiemann WP; Plow EF
    Cancer Res; 2017 Sep; 77(18):5129-5141. PubMed ID: 28687620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-Beta Mediates Homeostatic Synaptic Plasticity.
    Galanis C; Fellenz M; Becker D; Bold C; Lichtenthaler SF; Müller UC; Deller T; Vlachos A
    J Neurosci; 2021 Jun; 41(24):5157-5172. PubMed ID: 33926999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular trafficking of the amyloid precursor protein gene family and its pathogenic role in Alzheimer's disease.
    Kins S; Lauther N; Szodorai A; Beyreuther K
    Neurodegener Dis; 2006; 3(4-5):218-26. PubMed ID: 17047360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang X; Zhao F; Wang C; Zhang J; Bai Y; Zhou F; Wang Z; Wu M; Yang W; Guo J; Qi J
    Neurosci Bull; 2020 Mar; 36(3):254-262. PubMed ID: 31605298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice.
    Zhang MY; Zheng CY; Zou MM; Zhu JW; Zhang Y; Wang J; Liu CF; Li QF; Xiao ZC; Li S; Ma QH; Xu RX
    Neurobiol Aging; 2014 Dec; 35(12):2713-2725. PubMed ID: 25044076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.